About Kolon TissueGene
Kolon TissueGene is a private company based in Rockville, Maryland. It has reported $124,727,099 raised in four offerings on Form D since December 2021. Its chief executive is Moon Jong Noh.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 23, 2024 | Jun 5, 2024 | $34,999,709fully sold | 1 | $34.9M | EquityRule 506(b) | Form D ↗ |
| May 9, 2023 | May 15, 2023 | $30,000,024fully sold | 1 | $30.0M | EquityRule 506(b) | Form D ↗ |
| Aug 26, 2022 | Aug 29, 2022 | $29,637,774fully sold | 2 | $14.8M | EquityRule 506(b) | Form D ↗ |
| Dec 10, 2021 | Dec 16, 2021 | $30,089,592fully sold | 2 | $15.0M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $124,727,099 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kolon TissueGene's Form D filed Jun 5, 2024.
SK
Soon-Wook Kweon
Executive officer
YJ
Yonggyun Jeong
Executive officer
GP
Gun Young Park
Executive officer
SK
Sun Jin Kim
Executive officer
JK
Jung In Kim
Executive officer and director
SL
Sun Joo Lee
Director
CN
Charles Nye
Executive officer
YK
Young Kim
Executive officer
DH
Diana Halim
Executive officer
MN
Moon Jong Noh
President/CEO and director
Earlier filings also listed Sung Han (executive officer and director, last listed May 2023), Jangik Lee (director, last listed Aug 2022) and Min Seok Kim (executive officer and director, last listed Dec 2021).